Erlotinib vs Prochlorperazine
Erlotinib vs Prochlorperazine: Overview
This comparison examines the pharmacological differences between Erlotinib and Prochlorperazine.
Mechanism of Action
Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.
Pharmacokinetics
Half-life: Erlotinib β 36 hours.
Chemical Properties
Molecular Formula: Erlotinib β C22H23N3O4.
Molecular Weight: Erlotinib β 393.4380 g/mol.
Type: Erlotinib β Small molecule; Prochlorperazine β Small molecule.